Body mass index as a predictive factor for efficacy of adjuvant taxane-based chemotherapy in early-stage breast cancer patients: A pooled analysis from adjuvant GEICAM Spanish Breast Cancer Group and TRIO Translational Research in Oncology Group studies.
Saved in:
| Title: | Body mass index as a predictive factor for efficacy of adjuvant taxane-based chemotherapy in early-stage breast cancer patients: A pooled analysis from adjuvant GEICAM Spanish Breast Cancer Group and TRIO Translational Research in Oncology Group studies. |
|---|---|
| Authors: | García-Saenz JA; Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Spera G; Translational Research in Oncology, Medical Affairs, Montevideo, Uruguay., Pollán M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain.; Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain., Bermejo B; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Clínico Universitario de Valencia, INCLIVA Instituto de Investigación Sanitaria, Universidad de Medicina de Valencia, Valencia, Spain., Ruiz-Borrego M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Virgen del Rocío, Sevilla, Spain., Chan A; Curtin Medical School, Faculty of Health Sciences, Perth, Australia., Martín M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain.; Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, Madrid, Spain., Guerrero-Zotano Á; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Instituto Valenciano de Oncología, Valencia, Spain., Calvo L; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Complejo Hospitalario Universitario de la Coruña, A Coruña, Spain., Rodríguez-Lescure Á; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital General Universitario de Elche, Elche, Spain., Marín M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Consorci Sanitari de Terrassa, Terrassa, Spain., Chap L; Beverly Hills Cancer, Beverly Hills, Los Angeles, USA., Crown J; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland., Pienkowski T; Postgraduate Medical Education Center, Warsaw, Poland., Bee V; Translational Research in Oncology, Project Management, Paris, France., Casas M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Polonio Ó; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Bezares S; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Slamon D; Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine at the University of California, California, Los Angeles, USA. |
| Source: | International journal of cancer [Int J Cancer] 2025 Aug 15; Vol. 157 (4), pp. 709-721. Date of Electronic Publication: 2025 Apr 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40207789 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Body mass index as a predictive factor for efficacy of adjuvant taxane-based chemotherapy in early-stage breast cancer patients: A pooled analysis from adjuvant GEICAM Spanish Breast Cancer Group and TRIO Translational Research in Oncology Group studies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22García-Saenz+JA%22">García-Saenz JA</searchLink>; Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Spera+G%22">Spera G</searchLink>; Translational Research in Oncology, Medical Affairs, Montevideo, Uruguay.<br /><searchLink fieldCode="AU" term="%22Pollán+M%22">Pollán M</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain.; Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Bermejo+B%22">Bermejo B</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Clínico Universitario de Valencia, INCLIVA Instituto de Investigación Sanitaria, Universidad de Medicina de Valencia, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Ruiz-Borrego+M%22">Ruiz-Borrego M</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Virgen del Rocío, Sevilla, Spain.<br /><searchLink fieldCode="AU" term="%22Chan+A%22">Chan A</searchLink>; Curtin Medical School, Faculty of Health Sciences, Perth, Australia.<br /><searchLink fieldCode="AU" term="%22Martín+M%22">Martín M</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain.; Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Guerrero-Zotano+Á%22">Guerrero-Zotano Á</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Instituto Valenciano de Oncología, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Calvo+L%22">Calvo L</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Complejo Hospitalario Universitario de la Coruña, A Coruña, Spain.<br /><searchLink fieldCode="AU" term="%22Rodríguez-Lescure+Á%22">Rodríguez-Lescure Á</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital General Universitario de Elche, Elche, Spain.<br /><searchLink fieldCode="AU" term="%22Marín+M%22">Marín M</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Consorci Sanitari de Terrassa, Terrassa, Spain.<br /><searchLink fieldCode="AU" term="%22Chap+L%22">Chap L</searchLink>; Beverly Hills Cancer, Beverly Hills, Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Crown+J%22">Crown J</searchLink>; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Pienkowski+T%22">Pienkowski T</searchLink>; Postgraduate Medical Education Center, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Bee+V%22">Bee V</searchLink>; Translational Research in Oncology, Project Management, Paris, France.<br /><searchLink fieldCode="AU" term="%22Casas+M%22">Casas M</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Polonio+Ó%22">Polonio Ó</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Bezares+S%22">Bezares S</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Slamon+D%22">Slamon D</searchLink>; Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine at the University of California, California, Los Angeles, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220042124%22">International journal of cancer</searchLink> [Int J Cancer] 2025 Aug 15; Vol. 157 (4), pp. 709-721. <i>Date of Electronic Publication: </i>2025 Apr 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Liss%22">Wiley-Liss </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0042124 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0215 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200207136%22">00207136 </searchLink><i>NLM ISO Abbreviation: </i>Int J Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40207789 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/ijc.35432 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 709 Titles: – TitleFull: Body mass index as a predictive factor for efficacy of adjuvant taxane-based chemotherapy in early-stage breast cancer patients: A pooled analysis from adjuvant GEICAM Spanish Breast Cancer Group and TRIO Translational Research in Oncology Group studies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: García-Saenz JA – PersonEntity: Name: NameFull: Spera G – PersonEntity: Name: NameFull: Pollán M – PersonEntity: Name: NameFull: Bermejo B – PersonEntity: Name: NameFull: Ruiz-Borrego M – PersonEntity: Name: NameFull: Chan A – PersonEntity: Name: NameFull: Martín M – PersonEntity: Name: NameFull: Guerrero-Zotano Á – PersonEntity: Name: NameFull: Calvo L – PersonEntity: Name: NameFull: Rodríguez-Lescure Á – PersonEntity: Name: NameFull: Marín M – PersonEntity: Name: NameFull: Chap L – PersonEntity: Name: NameFull: Crown J – PersonEntity: Name: NameFull: Pienkowski T – PersonEntity: Name: NameFull: Bee V – PersonEntity: Name: NameFull: Casas M – PersonEntity: Name: NameFull: Polonio Ó – PersonEntity: Name: NameFull: Bezares S – PersonEntity: Name: NameFull: Slamon D IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 08 Text: 2025 Aug 15 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1097-0215 Numbering: – Type: volume Value: 157 – Type: issue Value: 4 Titles: – TitleFull: International journal of cancer Type: main |
| ResultId | 1 |
